LGALS3 Matched Antibody Pair (688) (APMAB-688LY)

Burbidge, K., Rademacher, D. J., Mattick, J., Zack, S., Grillini, A., Bousset, L., ... & Campbell, E. M. (2022). LGALS3 (galectin 3) mediates an unconventional secretion of SNCA/α-synuclein in response to lysosomal membrane damage by the autophagic-lysosomal pathway in human midbrain dopamine neurons. Autophagy, 18(5), 1020-1048.

Xu, W. D., Wu, Q., He, Y. W., Huang, A. F., Lan, Y. Y., Fu, L., ... & Liu, X. Y. (2021). Gene polymorphisms of LGALS2, LGALS3 and LGALS9 in patients with rheumatoid arthritis. Cellular Immunology, 368, 104419.

Rong, J., Pan, H., He, J., Zhang, Y., Hu, Y., Wang, C., ... & Zheng, Z. (2020). Long non-coding RNA KCNQ1OT1/microRNA-204-5p/LGALS3 axis regulates myocardial ischemia/reperfusion injury in mice. Cellular Signalling, 66, 109441.

Hu, W. M., Yang, Y. Z., Zhang, T. Z., Qin, C. F., & Li, X. N. (2020). LGALS3 is a poor prognostic factor in diffusely infiltrating gliomas and is closely correlated with CD163+ tumor-associated macrophages. Frontiers in Medicine, 7, 182.

Takashima, Y., Kawaguchi, A., Hayano, A., & Yamanaka, R. (2019). CD276 and the gene signature composed of GATA3 and LGALS3 enable prognosis prediction of glioblastoma multiforme. PloS one, 14(5), e0216825.

Li, Z., Lv, F., Dai, C., Wang, Q., Jiang, C., Fang, M., & Xu, Y. (2019). Activation of galectin-3 (LGALS3) transcription by injurious stimuli in the liver is commonly mediated by BRG1. Frontiers in cell and developmental biology, 7, 310.

Wang, H., Song, X., Huang, Q., Xu, T., Yun, D., Wang, Y., ... & Chen, J. (2019). LGALS3 promotes treatment resistance in glioblastoma and is associated with tumor risk and prognosis. Cancer Epidemiology, Biomarkers & Prevention, 28(4), 760-769.

He, X., Zhang, S., Chen, J., & Li, D. (2019). Increased LGALS3 expression independently predicts shorter overall survival in patients with the proneural subtype of glioblastoma. Cancer Medicine, 8(5), 2031-2040.

Zhang, Y., Wang, Y., Zhai, M., Gan, T., Zhao, X., Zhang, R., ... & Zhang, J. (2018). Influence of LGALS3 gene polymorphisms on susceptibility and prognosis of dilated cardiomyopathy in a Northern Han Chinese population. Gene, 642, 293-298.

Chaudoin, T. R., & Bonasera, S. J. (2018). Mice lacking galectin-3 (Lgals3) function have decreased home cage movement. BMC neuroscience, 19(1), 1-10.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme-Linked Immunospot (ELISpot)
Proteogenomics
Other Protocols

Alternative Versions

Mouse Anti-LGALS3 Recombinant Antibody

Related Products

Mouse Anti-LGALS3 Recombinant Antibody (9C4)

Mouse Anti-LGALS3 Recombinant Antibody (ZG001)

Rat Anti-LGALS3 Recombinant Antibody (5L36)

Rat Anti-LGALS3 Recombinant Antibody (eBioM3/38M3/38)

Mouse Anti-LGALS3 Recombinant Antibody (CBYJL-1519)

Mouse Anti-LGALS3 Recombinant Antibody (CBLG1-3225)

Rabbit Anti-LGALS3 Recombinant Antibody (CBYJL-1511)

Mouse Anti-LGALS3 Recombinant Antibody (B-E53)

Mouse Anti-LGALS3 Recombinant Antibody (CBYCL-265)

Mouse Anti-LGALS3 Recombinant Antibody (320CT4.5.2)

Isotype control